Again, some are effective but many are not. Some are accompanied by snake-oil hype that touts the “miracle” substance they’re peddling is going to cure everything. No one substance on the planet can cure all our ills, and anything that says it can is pure nonsense.
But the fact remains, we’re all going to have to face this dreaded disease either in ourselves or in those we love. So is cancer curable? I believe that it is. I also firmly believe that it is going to take the concerted efforts of both sides of this beleaguered and far too bloody battlefield to come up with a treatment that works, consistently and through time.
There is much to overcome. The pharmaceuticals have invested a ton of money into cancer research. That plus those who advertise cures with no scientific backup have made cancer into a “big business” venture because of the massive amounts of money involved in the manufacture and sale of both the natural “cures” and the pharmaceutical drugs.
We are tired of all the hype and the inevitable disappointment.
While I side firmly with those alternative natural therapies that are proven to work, we must be careful of all those dishonest practitioners who are out to make a quick buck. We must also educate ourselves on what works, what doesn’t, and the failings of the current offerings.
And that is where the genius of Dr. Mirko Beljanski can lead the way.
Outside the Box
In her published article, “The Beljanski Approach: Outside the Box,” Monique Beljanski explains one of the great failings of traditional cancer treatments: She states that chemotherapy and radiation are “cytotoxic,” meaning they are deadly to almost all fast-dividing cells in our body. The cancer chemicals are worse than toxic since chemotherapy, administered in any concentration—from the lowest to the highest volume and at all potencies—actually stimulates the growth of more cancer.
In other words, as Mme. Beljanski explained to me, “At low doses, these treatments happen to destabilize the DNA thereby increasing replication: they behave like carcinogens. At high doses, they act like toxins on the body.” To compound the problem, traditional methods of treatment weaken and even destroy the patient’s entire immune system at the very moment it is needed most.
There are a number of reasons why chemotherapy often fails on its own merits:
• It burdens the body’s detoxification system so that cellular waste products are allowed to accumulate.
It causes further destabilization of the cancer patient’s DNA which allows further out-of-control replication to take place.
It kills cells by damaging their DNA resistance to other chemicals in addition to the cytotoxic agents.
It encourages the “tumor suppressor gene” to mutate extraordinarily so that the mutated gene dominates the tumor’s growth and disallows any mutated cancer cells from dying.
In other words, no apoptosis (cell death) ever takes place. Cancer cells, with the help of the toxic chemicals continue to replicate out of control, thriving inside the victim’s tissues and organs.
Dr. Beljanski was well aware of toxic chemotherapy drugs used by oncologists and other medical doctors to treat malignancies. But he also had made it his life’s work to find substances that would work hand-inhand with traditional medicine.
He once said, “I want to help people. I want to find harmless ways to do it, but they should work in conjunction with standard therapies.” Although Mirko Beljanski was a scientist, not a physician, he had a deep and abiding sense of duty to use science for aiding his fellow human being. His Oncotest, he knew, could have helped prevent cancer by identifying any and all substances that were carcinogenic in nature. But since the industrial and pharmaceutical interests put an effective stop to that, Dr. Beljanski turned his keen and logical mind to another possible use for the Oncotest.
He reasoned that if potentially carcinogenic substances stimulate the replication of cancer DNA cells (the open-looped cells which replicate
ad infinitum
) but not healthy cells, then perhaps the reverse could be true as well. He asked himself the inevitable next question, “What if there were substances able to inhibit the out-of-control replication of the cancerous DNA—that is to say restabilize the cancerous DNA—but not affect the healthy cells?”
Dr. Beljanski turned his attention to finding some substance, some chemical, some botanical, or some other material that would
selectively
take out the cancerous DNA cells without harming the healthy ones. This is exactly what the standard chemotherapy treatments do
not
do. They’re not selective but rather equal-opportunity cell destroyers, and that’s what makes these treatments so harmful to the human body.
This idea, that there could be a selective cancer-fighting substance, seemed to be an unattainable dream. But therein lies an enormous problem. If you believe that something can’t be true, you deny its existence, even if, in fact, the thing you deny is true and real.
What Mirko Beljanski did find, indeed, are two botanicals that he scientifically tested again and again to prove that they do exactly what they purport to do—handle the cancerous, destabilized DNA cells replicating out of control without harming the healthy cells surrounding them.
Beljanski’s meticulous research opened the door to finding a solution to the problem of traditional cancer treatments lacking selectivity. It is an ideal solution and one that deserves to be examined more closely by both sides of the battlefield.
Introducing the Anticancer Botanicals
During the period when Dr. Beljanski and his wife were concentrating their attention on perfecting the Oncotest, a debate arose among pharmacologists and other doctors around the European continent concerning an African plant, identified botanically as
Rauwolfia vomitoria (R. vomitoria)
. It grew in a vast territory at the mid-sectional belt traversing West Africa, from the Ivory Coast to the Democratic Republic of the Congo. A commercial extract of the herb was rich in reserpine, an alkaloid found in the plant. Alkaloids are any of a class of nitrogen-based organic compounds of plant origin that have pronounced physiological actions on humans. Among them are morphine, quinine, caffeine and strychnine, and these are often used as the basis for medications such as pain relievers and anesthetics. A few of the alkaloids inhibit cell division, such as colchicine, which treats gout, but others of them can also be poisonous, as this short sample list indicates.
A few internists and psychiatrists had been using reserpine to treat patients with high blood pressure and psychiatric disorders. At that time, questions arose among the involved therapists as to whether the reserpine component was carcinogenic, and that question sparked a hot debate in the medical community. Nobody knew, but many scientists conjectured, about the alkaloid’s toxicity as a carcinogen.
Dr. Beljanski was intrigued by the debate about the reserpine alkaloid as well. In order to form his own opinion, he decided to evaluate the plant’s characteristics through the use of his Oncotest. With this test, the husband and wife team definitely had a leg up on their fellow scientists in regard to finding out quickly if that particular reserpine alkaloid was harmful or not. Their first task was to acquire a small quantity of this plant extract, which they were able to do within a week.
Upon carrying out a biochemical analysis of a commercially available reserpine-containing extract of
R. vomitoria
, Mirko and his team observed something odd. All living substances react to DNA at a certain rate. Scientists have discovered that this reaction rate shows up as a curve called “the kinetics of the curve,” when DNA is synthesized. The
R. vomitoria
curve looked abnormal, so Beljanski asked himself why.
One possibility for the abnormality in the graph was an intrusion of plant growth impurities, contaminants in the soil, or a mixture of compounds.
So Mirko suggested to Monique that they purify the extract, separate the various elements in the plants, called fractions, and then test each fraction separately using his Oncotest. These procedures took considerable time and energy, but the low cost and excellent efficiency of the Oncotest made their little intellectual game worthwhile. In the end, they reasoned that the extract contained a mixture of substances called alkaloids that had conflicting effects.
In reviewing the results of these experiments, Mirko and Monique were surprised to find that not only did one fraction of the extract, labeled
1-A
, exhibit carcinogenic potential, but a second fraction, marked
2-A
, whose nature they had not yet established,
completely prevented
cancerous DNA synthesis. Eventually, Beljanski was able to identify marker
2-A
as the alkaloid Alstonine, and it did something they had postulated but had never found before—it inhibited the replication cycle of the destabilized cell. Even more astounding, the alkaloid was indifferent to healthy cells. It only acted on cells that were cancerous or about to become cancerous.
Without DNA replication, a cell whether normal or cancerous, cannot multiply. So the team predicted that because it inhibited replication of a bad cell, the
2-A
fraction might suppress malignant tumors. This turned out to be the case. Beljanski found that the Alstonine molecule stopped cultures of cancer cells from growing
in vitro
—in fact, the cell cultures of cancer shrunk and disappeared.
Monique succinctly put it to me again when I met with her in the summer of 2006. It had been about three decades since those experiments, but her excitement was still palpable. She said, “That second
Rauwolfia vomitoria
fraction of
2-A
beautifully illustrated what a cancer-fighting substance should be!”
At the beginning of their investigations, the Beljanskis and their research team studied several alkaloids from the same botanical family, or closely related to the first one. But for various laboratory reasons, they finally concentrated on the
Rauwolfia
plant extract itself.
Finding the “Bolt” Molecule
At first incredulous about these results, Mirko and his team checked their experimental procedures repeatedly and under various conditions.
The results came up with the same, selective effects each time, and they decided that they had discovered something significant.
The researchers then carried out further analytical procedures to establish the molecular characteristics of each constituent in
Rauwolfia vomitoria
. This process was effective in isolating the important component that would later be called a “bolt molecule.” They then determined the chemical structure of the plant’s specific active factor—again it was Alstonine—which selectively inhibited the growth of cancerous DNA. Then because part of the
R. Vomitoria
is toxic, they developed the painstaking process to produce a highly purified extract that removes any harmful residue.
Bolt molecules, as defined by Dr. Beljanski, are the actual individual chemical constituents in a formula which bring about healing of malfunctioning cells, tissues, organs, and/or whole body parts.
After months of painstaking work, the researchers fully realized that finding the plant’s active factor may be of great therapeutic importance to victims of cancer. They labored diligently to acquire a much greater quantity of the plant and to purify larger amounts of the active component.
Ten years of hard work led to numerous additional analyses and tests as well as toxicology studies. The results were consistent and always striking: the concentrated and highly purified
Rauwolfia vomitoria
extract is rich in selective bolt molecules that inhibit almost all types of cancer cells. It also has a preference for hormonal tissues.
The Second Anticancer Alkaloid
Once Dr. Beljanski had discovered the bolt molecule in
R. vomitoria
, he went looking for other botanicals with the same types of alkaloids. He found a second promising substance that was derived from the powdered bark of a Brazilian rainforest tree. The plant is named Pao pereira (
Geissospermum velosii
), and knowledge about it has become invaluable for cancer treatment. Through another long series of laboratory tests, Beljanski and his team found that the bark of the Pao pereira, extracted and purified, induced apoptosis with its “bolt” molecule, Flavopereirine.
This is invaluable when fighting cancer because the most effective way to stop a cancer cell from replicating itself indefinitely is to get it to kill itself!
Because of their consistently promising results, Dr. Beljanski decided to focus his full attention on studying these two alkaloid extracts in depth. They have many properties in common, not the least of which is their ability to be selective and remain non-toxic while combating cancerous cells. The science of how they work is of course very complex, and one of the most important differences between the two substances is that the smaller Pao molecule is able to cross the human blood-brain barrier, while the
R. vomitoria
alkaloid cannot. (The blood-brain barrier is a tight cellular seal that prevents foreign chemicals from easily getting into the brain. Poisons cannot reach the brain because of it.)
This is important to know when dealing with brain cancers because the small Pao molecule provides help in such cases but
Rauwolfia
does not. More important, however, is that the two alkaloids have a wonderfully synergistic effect when put together, the one inhibiting the replication cycle, the other inducing cell death. It’s a one-two punch against the cancer cell that Beljanski found to work over and over in his laboratory experiments.
Demand Grows
Once physicians and patients found out about them, they clamored to obtain the two botanicals. In his book,
Extraordinary Healing
, Stephen Coles, M.D., reports that the first “bolt” molecules were discovered around the mid-1980s. The first requests from desperate patients looking for something to save their lives came to Dr. and Mme. Beljanski around 1986, and for almost a decade, they dispensed their botanical extracts throughout Western Europe, entirely as the result of word of mouth. Beljanski never did anything other than what a scientist should do—write up his findings in peer-reviewed scientific or medical journals. Dr. Coles makes it clear that Beljanski never publicized his findings or advertised the botanical extracts, but doctors reading about them in the scientific journals would contact him, asking him to supply them with his formulas. People would hear about the curative effects of the botanicals and contact the Beljanski laboratory, begging this microbiologist for his nutritional supplements.